Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 77.78 Million | 75.81 Million | 124.3 Million | 175.76 Million | 33.72 Million | 47.59 Million |
| Net Income | 80.87 Million | 116.1 Million | 100.6 Million | 74.1 Million | 70.86 Million | 70.39 Million |
| Depreciation & Amortization | 23.34 Million | 25.44 Million | 22.8 Million | 19.08 Million | 16 Million | 13.56 Million |
| Deferred income taxes | 1.74 Million | 5.44 Million | 1.33 Million | -4.25 Million | -3.95 Million | -413.2 Thousand |
| Stock-based compensation | -4.02 Million | - | - | - | - | - |
| Change in working capital | -44.54 Million | -83.29 Million | -21.51 Million | 60.9 Million | -64.15 Million | -37.94 Million |
| Other non-cash items | 18.1 Million | 2.15 Million | 22.4 Million | 21.67 Million | 11 Million | 1.57 Million |
| Investing Cash Flow | -96.69 Million | -79.17 Million | -217.6 Million | -326.66 Million | -3.34 Million | -26.79 Million |
| Investments in PPE | -101.7 Million | -129.2 Million | -105.69 Million | -68.14 Million | -156.07 Million | -40.54 Million |
| Acquisitions | 1.00 | 30 Thousand | 82 Thousand | 69.49 Million | 165.41 Million | 0.12 |
| Investment purchases | -1000.00 | -85 Million | -665 Million | -544.87 Million | -163.7 Million | -638 Million |
| Sales/Maturities of investments | 2823.09 | 135 Million | 553 Million | 285 Million | 307.08 Million | 653.94 Million |
| Other Investing Activities | 5 Million | - | - | -68.14 Million | -156.07 Million | -2.19 Million |
| Financing Cash Flow | 56.48 Million | 31.54 Million | -164.29 Million | 299.33 Million | 12.02 Million | 31.94 Million |
| Debt repayment | -404 Million | -278 Million | -418.63 Million | -236.99 Million | -257.37 Million | -139 Million |
| Dividends payments | -23.17 Million | -19.88 Million | -14.01 Million | -11.49 Million | -5.77 Million | -21.87 Million |
| Common Stock Repurchased | -2.98 Million | -2.2 Million | -15.02 Million | -2.69 Million | -16.92 Million | -15.97 Million |
| Common Stock Issuance | - | 2.2 Million | 27.81 Million | 2.69 Million | 16.92 Million | - |
| Other Financing Activities | -2.98 Million | 343.89 Million | 271.87 Million | 562.55 Million | 285.53 Million | 192.81 Million |
| Accounts receivables | 6.99 Million | -20.17 Million | -8.44 Million | 37.46 Million | -52.92 Million | -45.14 Million |
| Accounts payables | -52.08 Million | -1.8 Million | 25.94 Million | 20 Million | 4.85 Million | 23.62 Million |
| Inventory | -1.19 Million | -66.75 Million | -40.34 Million | 7.68 Million | -12.12 Million | -16 Million |
| Other working capital | 1.74 Million | 5.44 Million | 1.33 Million | -4.25 Million | -3.95 Million | -21.93 Million |
| Cash at beginning of period | 100.66 Million | 72.47 Million | 330.08 Million | 181.65 Million | 139.24 Million | 86.5 Million |
| Cash at end of period | 138.23 Million | 100.66 Million | 72.47 Million | 330.08 Million | 181.65 Million | 139.24 Million |
| Capital Expenditure | -101.7 Million | -129.2 Million | -105.69 Million | -68.14 Million | -156.07 Million | -40.54 Million |
| Effect of forex changes on cash | 123.37 | - | 0.12 | - | - | 0.31 |
| Net cash flow / Change in cash | 37.56 Million | 28.18 Million | -257.6 Million | 148.43 Million | 42.4 Million | 52.74 Million |
| Free Cash Flow | -23.91 Million | -53.38 Million | 18.6 Million | 107.61 Million | -122.34 Million | 7.05 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 30.66 Million | 14.76 Million | 15.57 Million | -6.84 Million | 80.87 Million | 41.38 Million |
| Depreciation & Amortization | - | 9.37 Million | 9.37 Million | 6.61 Million | 23.34 Million | -10.37 Million |
| Deferred income taxes | - | - | - | -1.77 Million | 1.74 Million | -51.45 Million |
| Stock-based compensation | - | 9.85 Million | - | -4.02 Million | -4.02 Million | -2.68 Million |
| Change in working capital | - | 26.62 Million | - | 5.79 Million | -44.54 Million | 64.52 Million |
| Other non-cash items | -8.42 Million | 6.47 Million | 5.03 Million | 41.85 Million | 18.1 Million | 9.27 Million |
| Investing Cash Flow | -5.72 Million | -25.7 Million | -13.48 Million | -23.94 Million | -96.69 Million | -13.37 Million |
| Investments in PPE | -10.72 Million | -25.7 Million | -13.56 Million | -28.95 Million | -101.7 Million | -13.37 Million |
| Acquisitions | 5 Million | - | 80 Thousand | 5 Million | 1.00 | - |
| Investment purchases | - | - | - | -1000.00 | -1000.00 | - |
| Sales/Maturities of investments | - | - | - | 1822.93 | 2823.09 | - |
| Other Investing Activities | 5 Million | - | 80 Thousand | 1000.00 | 5 Million | 0.16 |
| Financing Cash Flow | 47.01 Million | -53.56 Million | -4.75 Million | -82.38 Million | 56.48 Million | 39.24 Million |
| Debt repayment | -54 Million | -23 Million | -114 Million | -142 Million | -404 Million | -90 Million |
| Dividends payments | -5.63 Million | -20.04 Million | -4.18 Million | -23.17 Million | -23.17 Million | -4.4 Million |
| Common Stock Repurchased | 122.74 Million | -122.74 Million | - | -2.98 Million | -2.98 Million | 881.6 Thousand |
| Common Stock Issuance | - | - | - | - | - | -881.6 Thousand |
| Other Financing Activities | -1.34 Million | -10.52 Million | -114.57 Million | -752.64 Thousand | -2.98 Million | 133.64 Million |
| Accounts receivables | - | 7.25 Million | - | 6.99 Million | 6.99 Million | 69.42 Million |
| Accounts payables | - | - | - | - | -52.08 Million | - |
| Inventory | - | 19.37 Million | - | -1.19 Million | -1.19 Million | -4.9 Million |
| Other working capital | - | - | - | - | 1.74 Million | - |
| Cash at beginning of period | 73.19 Million | 140.6 Million | 138.23 Million | 202.94 Million | 100.66 Million | 126.41 Million |
| Cash at end of period | 136.71 Million | 73.19 Million | 140.6 Million | 138.23 Million | 138.23 Million | 202.94 Million |
| Capital Expenditure | -10.72 Million | -25.7 Million | -13.56 Million | -28.95 Million | -101.7 Million | -13.37 Million |
| Effect of forex changes on cash | - | - | - | 0.42 | 123.37 | 0.72 |
| Net cash flow / Change in cash | 63.52 Million | -67.41 Million | 2.36 Million | -64.7 Million | 37.56 Million | 76.52 Million |
| Free Cash Flow | 11.5 Million | -13.84 Million | 7.04 Million | 12.67 Million | -23.91 Million | 37.28 Million |
PROX
SEAL-PA
HTFC
PHGE
VLVOF
OSSIF